ATI Physical Therapy, Inc. (ATIP)
- Previous Close
4.0684 - Open
4.0700 - Bid 4.0700 x 800
- Ask 4.2200 x 4000
- Day's Range
4.0700 - 4.0700 - 52 Week Range
4.0000 - 14.5000 - Volume
103 - Avg. Volume
6,082 - Market Cap (intraday)
17.136M - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-31.9300 - Earnings Date May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
ATI Physical Therapy, Inc. operates as an outpatient physical therapy provider that specializes in outpatient rehabilitation and adjacent healthcare services in the United States. It offers a range of services to its patients, including physical therapy to treat spine, shoulder, knee, and neck injuries or pain; work injury rehabilitation services, work conditioning and work hardening; and hand therapy, aquatic therapy, functional capacity evaluation, sports medicine, and wellness programs. It also provides ATI worksite solutions comprising injury prevention programs, work-related injury assessment services, wellness offerings, and consultations for employers; proprietary electronic medical records (EMR) integration, caseload management, and continuing education in therapy treatments; and sports medicine, including on-site sports physical therapy, clinical evaluation and diagnosis, immediate and emergency care, nutrition programs, and concussion management services. The company offers outpatient physical therapy services under the ATI brand name. ATI Physical Therapy, Inc. was founded in 1996 and is based in Bolingbrook, Illinois.
www.atipt.com6,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ATIP
Performance Overview: ATIP
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATIP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATIP
Valuation Measures
Market Cap
17.13M
Enterprise Value
730.51M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.02
Price/Book (mrq)
--
Enterprise Value/Revenue
1.05
Enterprise Value/EBITDA
20.91
Financial Highlights
Profitability and Income Statement
Profit Margin
-10.15%
Return on Assets (ttm)
-1.78%
Return on Equity (ttm)
-42.18%
Revenue (ttm)
687.76M
Net Income Avi to Common (ttm)
-131.97M
Diluted EPS (ttm)
-31.9300
Balance Sheet and Cash Flow
Total Cash (mrq)
36.8M
Total Debt/Equity (mrq)
602.37%
Levered Free Cash Flow (ttm)
-9.69M